BOMCBD PEG
PEG Ratio (Price/Earnings-to-Growth) of BOMCBD (FMYR) as of Jul 26, 2026.
Get this data via API
Financial Data API
PEG
0.00
Last updated:
PEG Ratio (Price/Earnings-to-Growth) of BOMCBD is 2026 0.00 . PEG Ratio (Price/Earnings-to-Growth) of BOMCBD was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
BOMCBD Stock analysis
What does BOMCBD do? BOMCBD Corp is a company that operates in the cannabis industry. The company was founded in 2018 and is headquartered in California, USA.
The business model of BOMCBD Corp is based on the production and sale of CBD products for medical and recreational use. CBD stands for cannabidiol, a non-psychoactive compound found in the hemp plant that can provide a range of health benefits.
BOMCBD Corp has several divisions, each focused on different aspects of the company. The main division is the production of CBD products for medical use, including oils, capsules, liquids, and lotions that can be used for various diseases and ailments.
Another division of BOMCBD Corp is the distribution of CBD products for recreational use. Under this category, they offer smoking accessories and CBD flowers that can be used as an alternative to traditional tobacco smoking.
In addition to the CBD segment, BOMCBD Corp has also expanded into the psychedelics industry. Under the brand "BOMTripping," they produce and distribute products based on psychedelics, including psychoactive mushrooms and products containing DMT.
BOMCBD Corp's product range is diverse and includes a wide range of items. Most products are available in different concentrations and flavors to meet the varying needs of customers.
Another notable feature of BOMCBD Corp is its commitment to sustainability in product production. The company focuses on organic hemp cultivation and also collects all packaging materials for reuse or recycling.
The company also operates its own research department, which is used by scientists and laboratory tests to monitor the effectiveness and quality of the products produced. This increases customer confidence in BOMCBD Corp's products and has contributed to the company's establishment in the market.
Due to the success and growing popularity of the products, BOMCBD Corp plans to further expand into other markets and regions. Over the next few years, intensive development is planned, with the introduction of several new products to the market. The company also aims to expand its distribution network and form partnerships with other companies and organizations.
Overall, BOMCBD Corp is an innovative company that has firmly established itself in the cannabis and psychedelics industry. Their wide product range, commitment to sustainability, and constant effort to develop new products make the company an important player in the market. BOMCBD is one of the most popular companies on Eulerpool.
Frequently Asked Questions about BOMCBD stock
On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) BOMCBD since 2006 – with annual values, charts, and detailed analysis.
Access this data via the Eulerpool API
Valuation — BOMCBD
All Key Metrics — BOMCBD
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth